Cellular infiltrates and NFκB subunit c-rel signaling in kidney allografts of patients with clinical operational tolerance

Transplantation

Volumn 94, Issue 7, 2012, Pages 729-737

  Becker, Luis E ^a   De Oliveira Biazotto, Fúvia ^a,b   Conrad, Heike ^a   Schaier, Matthias ^a   Kihm, Lars P ^a   Gross Weissmann, Marie Luise ^a   Waldherr, Rüdiger ^a   Bierhaus, Angelika ^a   Nawroth, Peter P ^a   Zeier, Martin ^a   Morath, Christian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

c Rel; FOXP3; NFJB; PI3K; Tolerance

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR REL;

ADULT; ARTICLE; CELL COUNT; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL OPERATIONAL TOLERANCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE;

ADULT; BIOPSY; CHI-SQUARE DISTRIBUTION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-REL; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSPLANTATION TOLERANCE;

EID: 84867263974     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31826032be     Document Type: Article

References (47)

1. Azzi J, Sayegh MH. Clinical transplantation tolerance: a myth no more, butI. Am J Kidney Dis 2009; 54: 1005.
2. Orlando G, Hematti P, Stratta RJ, et al. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg 2010; 252: 915.
3. Ashton-Chess J, Giral M, Brouard S, et al. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 2007; 84: 1215.
4. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353.
5. Kirk AD, Turgeon NA, Iwakoshi NN. B cells and transplantation tolerance. Nat Rev Nephrol 2010; 6: 584.
6. Kirk AD, Jacobson LM, Heisey DM, et al. Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. Transplantation 1999; 68: 1578.
7. Cook CH, Bickerstaff AA, Wang JJ, et al. Spontaneous renal allograft acceptance associated with WregulatoryW dendritic cells and IDO. J Immunol 2008; 180: 3103.
8. 3+ T cells within tolerant renal allografts shows infiltration of tubules mimicking rejection. Am J Pathol 2007; 171: 1915.
9. 3+ regulatory T cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008; 19: 2020.
10. Xu Q, Lee J, Jankowska-Gan E, et al. Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol 2007; 178: 3983.
11. Luft TH, Maraskovsky E, Schnur M, et al. Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion in dentritic cells. Blood 2004; 104: 1066.
12. Wang C, Cordoba S, Hu M, et al. Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments. Transpl Immunol 2011; 24: 149.
13. Liu Q, Chen T, Chen G, et al. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-JB pathways. Mol Immunol 2007; 44: 2686.
14. Isermann B, Vinnikov IA, Madhusudhan T, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 2007; 13: 1349.
15. Schneider L, Hartwig W, Flemming T, et al. Protective effects and antiinflammatory pathways of exogenous calcitonin geneYrelated peptide in severe necrotizing pancreatitis. Pancreatology 2009; 9: 662.
16. Matsuda S, Mikami Y, Ohtani M, et al. Critical role of class IA PI3K for c-Rel expression in B lymphocytes. Blood 2009; 113: 1037.
17. Vang KB, Yang J, Pagán AJ, et al. Cutting edge: CD28 and c-RelY dependent pathways initiate regulatory T cell development. J Immunol 2010; 184: 4074.
18. Kisielewicz A, Schaier M, Schmitt E, et al. A distinct subset of HLADR+ Yregulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation. Clin Immunol 2010; 137: 209.
19. Cosio FG, Grande JP, Wadei H, et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464.
20. Calne RY. Prope tolerance: the future of organ transplantationVfrom the laboratory to the clinic. Transplantation 2004; 77: 930.
21. Brouard S, Mansfield E, Braud C, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007; 104: 15448.
22. 3+ regulatory T cells in renal transplant recipients. Trasnplantation 2006; 82: 550.
23. Tsaur I, Gasser M, Aviles B, et al. Donor antigenYspecific regulatory Tcell function affects outcome in kidney transplant recipients. Kidney Int 2011; 79: 1005.
24. Grimbert P, Audard V, Diet C, et al. T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated costimulatory blockade. Nephrol Dial Transplant 2011; 26: 1087.
25. Ashton-Chess J, Dugast E, Colvin RB, et al. Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol 2009; 20: 1113.
26. Girlanda R, Kleiner DE, Duan Z, et al. Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant 2008; 8: 600.
27. Pallier A, Hillion S, Danger R, et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010; 78: 503.
28. Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836.
29. Sagoo P, Perucha E, Sawitzki B, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010; 120: 1848.
30. Bestard O, Cruzado JM, Mestres M, et al. Induction of donor specific cellular hyporesponse is feasible after renal transplantation by a calcineurin-inhibitor and steroid-free immunosuppressive protocol. Am J Transplant 2006; 6: 170.
31. Bunnag S, Allanach K, Jhangri GS, et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008; 8: 1423.
32. Kim SH, Ahn HJ, Kim YS, et al. Urinary HLA-DR and CD54 expressionVindicators for inflammatory activity in decoy cell shedding patients. Nephrol Dial Transplant 2006; 21: 2601.
33. Li Y, Yan H, Xue WJ, et al. Allograft rejectionYrelated gene expression in the endothelial cells of renal transplantation recipients after cytomegalovirus infection. J Zhejiang Univ Sci 2009; 10: 820.
34. Ozdemir BH, Aksoy PK, Haberal AN, et al. Relationship of HLA-DR expression to rejection and mononuclear cell infiltration in renal allograft biopsies. Ren Fail 2004; 26: 247.
35. Woltman AM, de Fijter JW, Zuidwijk K, et al. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 2007; 71: 1001.
36. Ching CB, Hansel DE. Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway. Lab Invest 2010; 90: 1406.
37. Soleimanpour SA, Crutchlow MF, Ferrari AM, et al. Calcineurin signaling regulates human islet {beta}-cell survival. J Biol Chem 2010; 285: 40050.
38. Jovanovic V, Giacomelli L, Sivozhelezov V, et al. AKT1 leader gene and downstream targets are involved in a rat model of kidney allograft tolerance. J Cell Biochem 2010; 111: 709.
39. Zhao L, Lee JY, Hwang DH. The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-JB pathway. Biochem Pharmacol 2008; 75: 1515.
40. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005; 9: 59.
41. Köntgen F, Grumont RJ, Strasser A, et al. Mice lacking the c-rel protooncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 1995; 9: 1965.
42. Campbell IK, Gerondakis S, O'Donnell K, et al. Distinct roles for the NF-JB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest 2000; 105: 1799.
43. Hori S. c-Rel: a pioneer in directing regulatory T-cell lineage commitment? Eur J Immunol 2010; 40: 664.
44. Espeli M, Bökers S, Giannico G, et al. Local renal autoantibody production in lupus nephritis. J Am Soc Nephrol 2011; 22: 296.
45. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
46. Dikow R, Becker LE, Schaier M, et al. In renal transplants with delayed graft function chemokines and chemokine receptor expression predict long-term allograft function. Transplantation 2010; 90: 771.
47. Mengel M, Gwinner W, Schwarz A, et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7: 356.